Citadel Advisors »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Citadel Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.5M 7.1M 1.20

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Linden Advisors
Ubs Global Asset Management Americas
Readystate Asset Management
Lazard Asset Management
Calamos Advisors
MacKay Shields
DeepCurrents Investment Group
Context Capital Management
Advent Capital Management
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Oaktree Capital Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1